TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 21, Issue 12, Pages 1717-1725
Publisher
Springer Nature
Online
2016-02-23
DOI
10.1038/mp.2016.6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
- (2015) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications
- (2015) Chiara Fabbri et al. Current Psychiatry Reports
- A genome-wide association study of antidepressant response in Koreans
- (2015) W Myung et al. Translational Psychiatry
- The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
- (2015) J M Biernacka et al. Translational Psychiatry
- Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations
- (2014) Yuan Ji et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Downregulation of Notch Modulators, Tetraspanin 5 and 10, Inhibits Osteoclastogenesis in Vitro
- (2014) Jian Zhou et al. CALCIFIED TISSUE INTERNATIONAL
- Modulating the serotonin system in the treatment of major depressive disorder
- (2014) Debbi Ann Morrissette et al. CNS SPECTRUMS
- Understanding the pharmacogenetics of selective serotonin reuptake inhibitors
- (2014) Chiara Fabbri et al. Expert Opinion on Drug Metabolism & Toxicology
- Treatment Outcomes of Depression
- (2014) David A. Mrazek et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics
- (2014) Mohan Liu et al. MOLECULAR ENDOCRINOLOGY
- Genetic variability in the regulation of gene expression in ten regions of the human brain
- (2014) Adaikalavan Ramasamy et al. NATURE NEUROSCIENCE
- Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
- (2014) Gonzalo Laje et al. PSYCHIATRIC SERVICES
- Risks of all-cause and suicide mortality in mental disorders: a meta-review
- (2014) Edward Chesney et al. World Psychiatry
- Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
- (2013) et al. AMERICAN JOURNAL OF PSYCHIATRY
- Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics
- (2013) L M Yerges-Armstrong et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
- (2013) M.S. Monteiro et al. CURRENT MEDICINAL CHEMISTRY
- Antidepressant pharmacogenetics
- (2013) Ajeet B. Singh et al. CURRENT OPINION IN PSYCHIATRY
- TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression
- (2013) Mohan Liu et al. MOLECULAR ENDOCRINOLOGY
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Systematic identification of trans eQTLs as putative drivers of known disease associations
- (2013) Harm-Jan Westra et al. NATURE GENETICS
- Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
- (2013) Hongjie Zhu et al. PLoS One
- Pharmacogenetics in major depression: A comprehensive meta-analysis
- (2013) Tomihisa Niitsu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF423 Regulation of BRCA1 Expression: Individualized Breast Cancer Prevention
- (2013) J. N. Ingle et al. Cancer Discovery
- Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
- (2013) R Kaddurah-Daouk et al. Translational Psychiatry
- The TspanC8 Subgroup of Tetraspanins Interacts with A Disintegrin and Metalloprotease 10 (ADAM10) and Regulates Its Maturation and Cell Surface Expression
- (2012) Elizabeth J. Haining et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals
- (2012) Emmanuel Dornier et al. JOURNAL OF CELL BIOLOGY
- Notch-Rbpj signaling is required for the development of noradrenergic neurons in the mouse locus coeruleus
- (2012) M. Shi et al. JOURNAL OF CELL SCIENCE
- Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation
- (2012) Ryan Abo et al. Pharmacogenetics and Genomics
- Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics
- (2012) Y Ji et al. PHARMACOGENOMICS JOURNAL
- Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis
- (2012) Katherine E. Tansey et al. PLOS MEDICINE
- Cross-national epidemiology of DSM-IV major depressive episode
- (2011) Evelyn Bromet et al. BMC Medicine
- Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: A Retrospective US Claims Study
- (2011) Heather D. Anderson et al. CLINICAL THERAPEUTICS
- Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
- (2010) Rudolf Uher et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics
- (2010) Y Ji et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Relevance of Norepinephrine-Dopamine Interactions in the Treatment of Major Depressive Disorder
- (2010) Mostafa El Mansari et al. CNS Neuroscience & Therapeutics
- Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
- (2010) N. Niu et al. GENOME RESEARCH
- A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells
- (2010) C. D. Dunn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
- (2009) Holly A. Garriock et al. BIOLOGICAL PSYCHIATRY
- The Notch signaling pathway: Transcriptional regulation at Notch target genes
- (2009) T. Borggrefe et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Gemcitabine and Cytosine Arabinoside Cytotoxicity: Association with Lymphoblastoid Cell Expression
- (2008) L. Li et al. CANCER RESEARCH
- Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder
- (2008) María Eugenia Hernández et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A comparison of antidepressant use in Nova Scotia, Canada and Australia
- (2008) Alesha J Smith et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation
- (2008) Fang Li et al. Pharmacogenetics and Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started